Cecilia Carpio

13PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 10, 2026
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

|Feb 14, 2026
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis.

Victor Navarro, Gloria Iacoboni, Sergi Camarillas

|Nov 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Roberto García-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado

|Aug 20, 2025
Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy.

Elżbieta Iskierka-Jażdżewska, Won Seog Kim, Seok-Goo Cho

|Jul 27, 2025
A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial.

Cecilia Carpio, Fátima de la Cruz-Vicente, Ramon García-Sanz

|May 22, 2025
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders.

Ángel Serna, Víctor Navarro, Moraima Jiménez

Pageof 3

Frequent Collaborators

4 joint publications

Gloria Iacoboni

4 joint publications

Pere Barba

3 joint publications

Víctor Navarro

2 joint publications

Mariana Bastos-Oreiro